---
figid: PMC8263639__ajcr0011-2867-f6
figtitle: Tipping-point for apoptosis following dual inhibition of HER2 signaling
  network by T-DM1 plus GDC-0980 maximizes anti-tumor efficacy
organisms:
- NA
pmcid: PMC8263639
filename: ajcr0011-2867-f6.jpg
figlink: /pmc/articles/PMC8263639/figure/fig06/
number: F6
caption: 'Homo or hetero dimerization of HER2 and HER3 (HER2:HER2 or HER2:HER3) and
  its downstream RAS-RAF-MEK or PI3K-AKT-mTOR signaling pathway: Activated AKT following
  stimulation of PI3K pathway drives mTOR-mediated CAP-dependent mRNA translation
  and also downregulates apoptosis via GSK3beta-BIM, XIAP-caspase and BAD-BCL2 pathways.
  mTOR regulates HIF1alpha translation, which eventually controls HIF1alpha-VEGF mediated
  tumor angiogenesis. RAS-RAF-MEK-ERK pathway regulates key signaling for tumorigenesis
  via protein translation, and cell survival/proliferation. Various targeted inhibitors
  of HER2 and PI3K-mTORC1/2 such as trastuzumab/T-DM1 and GDC-0980 respectively are
  presented.'
papertitle: A tipping-point for apoptosis following dual inhibition of HER2 signaling
  network by T-DM1 plus GDC-0980 maximizes anti-tumor efficacy.
reftext: Nandini Dey, et al. Am J Cancer Res. 2021;11(6):2867-2892.
year: '2021'
doi: ''
journal_title: American Journal of Cancer Research
journal_nlm_ta: Am J Cancer Res
publisher_name: e-Century Publishing Corporation
keywords: Breast cancer | HER2+ | PIK3CA mutation | angiogenesis | apoptosis | trastuzumab-sensitive
  | trastuzumab-resistant
automl_pathway: 0.8539732
figid_alias: PMC8263639__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8263639__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8263639__ajcr0011-2867-f6.html
  '@type': Dataset
  description: 'Homo or hetero dimerization of HER2 and HER3 (HER2:HER2 or HER2:HER3)
    and its downstream RAS-RAF-MEK or PI3K-AKT-mTOR signaling pathway: Activated AKT
    following stimulation of PI3K pathway drives mTOR-mediated CAP-dependent mRNA
    translation and also downregulates apoptosis via GSK3beta-BIM, XIAP-caspase and
    BAD-BCL2 pathways. mTOR regulates HIF1alpha translation, which eventually controls
    HIF1alpha-VEGF mediated tumor angiogenesis. RAS-RAF-MEK-ERK pathway regulates
    key signaling for tumorigenesis via protein translation, and cell survival/proliferation.
    Various targeted inhibitors of HER2 and PI3K-mTORC1/2 such as trastuzumab/T-DM1
    and GDC-0980 respectively are presented.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB2
  - KRAS
  - HRAS
  - NRAS
  - XYLT2
  - SOS1
  - SOS2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - GAB1
  - PIGU
  - GRB2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - ERBB3
  - PTEN
  - TSC2
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - EIF4EBP1
  - XIAP
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - RPS6KB1
  - RICTOR
  - BAD
  - BCL2
  - GSK3B
  - MCL1
  - HIF1A
  - EPAS1
  - HIF3A
  - BCL2L11
---
